Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Characterization of SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene in lung cancer
FY 2019-20
Summary
"Lung cancer is the deadliest type of cancer worldwide, with over 1.8 million people dying from it every year. By the time most people find out that they have lung cancer, the disease is already in its late stages where the tumor is growing fast and has started to spread throughout the body. There are only a small number of treatments for late stage lung cancer, which are largely ineffective and expensive. Being able to predict for individuals at high risk for lung cancer would be incredibly helpful for doctors to identify and treat people in earlier stages, but there are currently no tools to do so. The main cause of lung cancer is smoking, yet people who never smoke also get it. This suggests that other factors, such as genetics, can increase one's risk. SHPRH is a protein that helps fix damaged DNA. The genetic code for SHPRH is found in a region of DNA linked to increasing the chance of getting lung cancer passed on through the family. Data from our lab also shows that SHPRH is frequently deleted in people with lung cancer who have never smoked. But, the specific role of SHPRH in lung cancer has yet to be defined. This proposal aims to study the effect of SHPRH on the repair of damaged DNA and the development of lung cancer. We believe that SHPRH may act to help prevent lung tumors, whereby its inactivation increases the build-up of damaged DNA and mutations caused by DNA damaging agents such as those in tobacco smoke. These mutations will ultimately lead to the enhanced formation and progression of lung tumors. This research may highlight the use of SHPRH as a marker to screen for people who are at-risk for lung cancer, and direct early intervention and treatment methods that will improve the survival of those affected by this devastating disease. "
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
429176
Name
Sihota Tianna S
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of SNF2 Histone Linker PHD RING Helicase as a novel tumor suppressor gene in lung cancer
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Carcinogens; Crispr; Dna Damage; Dna Repair; Genomic Instability; Lung Cancer; Lung Tumorigenesis; Mouse Xenografts; Susceptibility Genes; Tumor Suppressor
Abstract
"Lung cancer is the deadliest type of cancer worldwide, with over 1.8 million people dying from it every year. By the time most people find out that they have lung cancer, the disease is already in its late stages where the tumor is growing fast and has started to spread throughout the body. There are only a small number of treatments for late stage lung cancer, which are largely ineffective and expensive. Being able to predict for individuals at high risk for lung cancer would be incredibly helpful for doctors to identify and treat people in earlier stages, but there are currently no tools to do so. The main cause of lung cancer is smoking, yet people who never smoke also get it. This suggests that other factors, such as genetics, can increase one's risk. SHPRH is a protein that helps fix damaged DNA. The genetic code for SHPRH is found in a region of DNA linked to increasing the chance of getting lung cancer passed on through the family. Data from our lab also shows that SHPRH is frequently deleted in people with lung cancer who have never smoked. But, the specific role of SHPRH in lung cancer has yet to be defined. This proposal aims to study the effect of SHPRH on the repair of damaged DNA and the development of lung cancer. We believe that SHPRH may act to help prevent lung tumors, whereby its inactivation increases the build-up of damaged DNA and mutations caused by DNA damaging agents such as those in tobacco smoke. These mutations will ultimately lead to the enhanced formation and progression of lung tumors. This research may highlight the use of SHPRH as a marker to screen for people who are at-risk for lung cancer, and direct early intervention and treatment methods that will improve the survival of those affected by this devastating disease. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sihota, Tianna S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~